Results 211 to 220 of about 4,104,552 (244)
Global Burden of Major Chronic Liver Diseases in 2021
Liver InternationalBackground: This study utilised the Global Burden of Disease data (2010–2021) to analyse the rates and trends in point prevalence, annual incidence and years lived with disability (YLDs) for major chronic liver diseases, such as hepatitis B, hepatitis C,
Nahum Mendez-Sanchez +1 more
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nutrition and Chronic Liver Disease
Journal of Clinical Gastroenterology, 2002Nutritional abnormalities almost uniformly accompany the metabolic disturbances of severe chronic liver disease and may adversely affect patient well-being and survival, especially surrounding liver transplantation surgery. The exact metabolic alterations responsible for malnutrition and its consequences in these patients have been debated and are a ...
Carla, Matos +3 more
openaire +2 more sources
Osteoporosis in Chronic Liver Disease
Nutrition in Clinical Practice, 2012Osteoporosis is a common skeletal complication seen in patients with chronic liver disease. Osteoporosis is usually asymptomatic and, if untreated, can result in fractures and impaired quality of life. For this review, we performed a systematic search of the PubMed database, and all recent peer‐reviewed articles regarding the prevalence ...
Anitha, Yadav, Elizabeth J, Carey
openaire +2 more sources
Anticoagulation in chronic liver disease
Journal of Hepatology, 2017In this Grand Round presentation, the case of a man with decompensated liver disease is described. He subsequently developed a fatal pulmonary embolism, which may not have occurred if he had been prescribed prophylactic anticoagulation to prevent venous thromboembolic disease.
Ameet, Dhar +2 more
openaire +2 more sources
Angiotensinogen in chronic liver disease
Scandinavian Journal of Clinical and Laboratory Investigation, 1992The renin substrate angiotensinogen (AGT) belongs to a supergene family of proteins that also includes alpha 1-antitrypsin (AAT) and alpha 1-antichymotrypsin (ACT), acute-phase reactants with known serine proteinase inhibitory (serpin) function. AGT lacks a known inhibitory function but is an acute-phase reactant.
K, Sjöberg, R, Alm, S, Eriksson
openaire +2 more sources
Chronic Liver Disease and Acetaminophen
Annals of Internal Medicine, 1977A 59-year-old female patient with arthritis developed liver function abnormalities while taking therapeutic doses of acetaminophen. Liver biopsy showed evidence of acute and chronic liver damage. Rechallenge with acetaminophen induced abnormal liver functions almost immediately. The patient has been followed for 2 years since that challenge and remains
G K, Johnson, K G, Tolman
openaire +2 more sources
Primary Care: Clinics in Office Practice, 2011
Regardless of etiology, chronic liver disease generally involves a process of progressive destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. At an early stage, most patients are asymptomatic and can easily go undiagnosed and untreated.
openaire +2 more sources
Regardless of etiology, chronic liver disease generally involves a process of progressive destruction and regeneration of the liver parenchyma, leading to fibrosis and cirrhosis. At an early stage, most patients are asymptomatic and can easily go undiagnosed and untreated.
openaire +2 more sources
Chronic liver diseases: From development to novel pharmacological therapies: IUPHAR Review 37
British Journal of Pharmacology, 2023Derek Mann, Maria Teresa Borrello
exaly
Lipoxygenases in chronic liver diseases: current insights and future perspectives
Trends in Pharmacological Sciences, 2022Ruchi Bansal, Amit Khurana, Ruchi Bansal
exaly
Cellular senescence in liver fibrosis: Implications for age-related chronic liver diseases
Expert Opinion on Therapeutic Targets, 2021Usa Chaikledkaew +2 more
exaly